SLC5A2 and obstructive sleep apnea syndrome: A comparison of the origin, mechanistic, and pharmacological effects of both classes of the above-mentioned antidiabetic drugs (GLP-1RAs and SGLT2 Inhibitors), primarily used in the treatment of OSA in T2DM patients, is presented in Table 4.